BFLY Butterfly Network
- 1.035
- -0.005-0.48%
Butterfly Network News
Buy Rating Affirmed: Butterfly Network's Growth and Innovation With IQ+ Bladder Launch
Butterfly Network Enters the Bladder Scanning Market With First Specialty Product, IQ+ Bladder, in the United States
With iQ+ Bladder, Butterfly expands outside its core point-of-care ultrasound market to better serve the bladder scanning market with its proprietary Ultrasound-on-Chip technology. The bundled bladder
Have Butterfly Network Insiders Been Selling Stock?
We note that the Butterfly Network, Inc. (NYSE:BFLY) Executive VP, Heather Getz, recently sold US$57k worth of stock for US$0.95 per share. It might not be a huge sale, but it did reduce their hold
Analysts Offer Insights on Healthcare Companies: Alignment Healthcare (ALHC), Butterfly Network (BFLY) and Deciphera Pharmaceuticals (DCPH)
Earnings Update: Here's Why Analysts Just Lifted Their Butterfly Network, Inc. (NYSE:BFLY) Price Target To US$3.38
As you might know, Butterfly Network, Inc. (NYSE:BFLY) just kicked off its latest first-quarter results with some very strong numbers. Results overall were credible, with revenues arriving 5.1% b
Earnings Call Summary | Butterfly Network(BFLY.US) Q1 2024 Earnings Conference
The following is a summary of the Butterfly Network, Inc. (BFLY) Q1 2024 Earnings Call Transcript:Financial Performance:Butterfly Network reported a Q1 2024 revenue of $17.7 million, marking a 14% inc
Butterfly Network (BFLY) Receives a Buy From Oppenheimer
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersAllarity Therapeutics (NASDAQ:ALLR) stock moved upwards by 106.6% to $2.83 during Thursday's pre-market session. The market value of their outstanding shares is at $5.5 million. Emergent BioSol
Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
Shares of Aspen Aerogels, Inc. (NYSE:ASPN) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results.Aspen Aerogels posted a GAAP loss
Butterfly Network Inc (BFLY) Q1 2024 Earnings Call Transcript Highlights: Revenue Growth and ...
Butterfly Network Inc (BFLY) Surpasses Q1 Revenue Expectations and Raises 2024 Guidance
Butterfly Network Now Sees FY24 Revenue Of $75M-$80M (Est $72.855M) Or Approximately 15-20% Revenue Growth (Prior View Low Double Digit Revenue Growth)
The company sees Adjusted EBITDA loss of $55 million - $50 million versus prior view of Adjusted EBITDA loss of $60 million - $50 million.
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersPulmonx (NASDAQ:LUNG) shares rose 29.5% to $10.0 during Wednesday's after-market session. The market value of their outstanding shares is at $388.1 million. The company's, Q1 earnings came out
Earnings Flash (BFLY) BUTTERFLY NETWORK Reports Q1 Revenue $17.7M, Vs. Street Est of $16.8M
04:27 PM EDT, 05/01/2024 (MT Newswires) -- Earnings Flash (BFLY) BUTTERFLY NETWORK Reports Q1 Revenue $17.7M, vs. Street Est of $16.8M
Butterfly Network Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results.
Butterfly Network Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results.
Butterfly Network Q1 2024 Adj EPS $(0.07) Beats $(0.12) Estimate, Sales $17.656M Beat $16.800M Estimate
Butterfly Network (NYSE:BFLY) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.12) by 41.67 percent. This is a 36.36 percent increase over losses of $(0.
Butterfly Network Raises Full Yr Guidance
Butterfly Network Raises Full Yr Guidance
Butterfly Network Raises FY24 View To Rev $75M-$80M >BFLY
Butterfly Network Raises FY24 View To Rev $75M-$80M >BFLY
Butterfly Network 1Q Loss/Shr 10c >BFLY
Butterfly Network 1Q Loss/Shr 10c >BFLY
Press Release: Butterfly Network Reports First Quarter 2024 Financial Results
Butterfly Network Reports First Quarter 2024 Financial Results Achieves 14% Revenue Growth - Exceeding Expectations Raises Full Year Guidance -- Delivered record first quarter Revenue of $17.7
Analysis
Price Target
No Data
